World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
139
Citations
94265
World Ranking
1725
National Ranking
988

Gary H. Lyman publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Gary H. Lyman sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 938 publications — 93rd percentile

93% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Gary H. Lyman D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Gary H. Lyman sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 139 D-Index — 92nd percentile

92% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Gary H. Lyman is affiliated with the Fred Hutchinson Cancer Research Center in the United States. Their research spans primarily the field of Medicine, with a particular focus on Oncology, alongside Economics and Econometrics, Public Health, Environmental and Occupational Health, Infectious Diseases, and Internal Medicine.

The scientist has contributed to several key topics in cancer and healthcare research including:

  • COVID-19 and healthcare impacts
  • Neutropenia and Cancer Infections
  • Economic and Financial Impacts of Cancer
  • Health Systems, Economic Evaluations, Quality of Life
  • Venous Thromboembolism Diagnosis and Management
  • COVID-19 Clinical Research Studies
  • Cancer Treatment and Pharmacology

Frequent coauthors collaborating with Gary H. Lyman include Nicole M. Kuderer, Petros Grivas, Jeremy L. Warner, Aakash Desai, and Dimpy P. Shah. These repeated partnerships reflect ongoing research efforts in cancer and related clinical studies.

Their work has been published in various scientific venues with most contributions found in Cancer Investigation, Journal of Clinical Oncology, Blood, Cancer Research, and UNC Libraries. These journals host a significant number of their publications, reflecting a continuous engagement with advancing oncology and clinical research.

Selected notable publications authored or coauthored by Gary H. Lyman include:

  • "Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study," 2020, The Lancet
  • "American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer," 2021, Blood Advances
  • "Antiemetics: ASCO Guideline Update," 2020, Journal of Clinical Oncology
  • "Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium," 2021, Annals of Oncology
  • "Integrative Medicine for Pain Management in Oncology: Society for Integrative Oncology-ASCO Guideline," 2022, Journal of Clinical Oncology

The research output of Gary H. Lyman has contributed extensively to understanding the interface of cancer treatment with infectious diseases, particularly in the context of the COVID-19 pandemic. Their work also addresses venous thromboembolism management and integrates clinical guidelines to support treatment decisions in oncology settings.

Best Publications

  • Prognostic Factors Analysis of 17,600 Melanoma Patients: Validation of the American Joint Committee on Cancer Melanoma Staging System

    Charles M. Balch;Seng-Jaw Soong;Jeffrey E. Gershenwald;John F. Thompson

  • American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline

    Carolyn D. Runowicz;Corinne R. Leach;N. Lynn Henry;Karen S. Henry

  • American Society of Clinical Oncology Guideline Recommendations for Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer

    Gary H. Lyman;Armando E. Giuliano;Mark R. Somerfield;Al B. Benson

  • Development and validation of a predictive model for chemotherapy-associated thrombosis

    Alok A. Khorana;Nicole M. Kuderer;Eva Culakova;Gary H. Lyman

  • Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy

    Alok A. Khorana;C. W. Francis;E. Culakova;N. M. Kuderer

  • Reduction by Granulocyte Colony-Stimulating Factor of Fever and Neutropenia Induced by Chemotherapy in Patients with Small-Cell Lung Cancer

    Jeffrey Crawford;Howard Ozer;Ronald Stoller;David H Johnson

  • Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study.

    Nicole M. Kuderer;Toni K. Choueiri;Dimpy P. Shah;Yu Shyr

  • Lymphatic mapping and sentinel node biopsy in the patient with breast cancer

    John J. Albertini;Gary H. Lyman;Charles Cox;Tim Yeatman

  • 2006 Update of Recommendations for the Use of White Blood Cell Growth Factors: An Evidence-Based Clinical Practice Guideline

    Thomas J. Smith;James Khatcheressian;Gary H. Lyman;Howard Ozer

  • American Society of Clinical Oncology Guideline: Recommendations for Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer

    Gary H. Lyman;Alok A. Khorana;Anna Falanga;Daniel Clarke-Pearson

  • Recommendations on the Use of 18F-FDG PET in Oncology

    James W. Fletcher;James W. Fletcher;Benjamin Djulbegovic;Heloisa P. Soares;Barry A. Siegel

  • Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update

    Nigel S Key;Alok A Khorana;Nicole M Kuderer;Kari Bohlke

  • Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D)

    Annie M. Young;Andrea Marshall;Jenny Thirlwall;Oliver Chapman

  • Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update 2014

    Gary H. Lyman;Gary H. Lyman;Kari Bohlke;Alok A. Khorana;Nicole M. Kuderer

  • 2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours

    M. S. Aapro;J. Bohlius;David Cameron;Lissandra Dal Lago

  • Comorbidity and functional status are independent in older cancer patients.

    Martine Extermann;Janine Overcash;Gary H. Lyman;Joyce Parr

  • Sentinel Lymph Node Biopsy for Patients With Early-Stage Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update

    Gary H. Lyman;Sarah Temin;Stephen B. Edge;Lisa A. Newman

  • Predicting the risk of chemotherapy toxicity in older patients: The Chemotherapy Risk Assessment Scale for High‐Age Patients (CRASH) score

    Martine Extermann;Ivette Boler;Richard R. Reich;Richard R. Reich;Gary H. Lyman

  • Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update

    Paul J. Hesketh;Mark G. Kris;Ethan Martin Basch;Kari Bohlke

  • American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options

    Lowell E. Schnipper;Nancy E. Davidson;Dana S. Wollins;Courtney Tyne

Frequent Co-Authors

Jeffrey Crawford
Jeffrey Crawford Duke University
David C. Dale
David C. Dale University of Washington
Alok A. Khorana
Alok A. Khorana Cleveland Clinic
Scott D. Ramsey
Scott D. Ramsey Fred Hutchinson Cancer Research Center
Lodovico Balducci
Lodovico Balducci University of South Florida
Charles W. Francis
Charles W. Francis University of Rochester Medical Center
Douglas S. Reintgen
Douglas S. Reintgen University of South Florida
Charles E. Cox
Charles E. Cox University of South Florida
Benjamin Djulbegovic
Benjamin Djulbegovic City Of Hope National Medical Center
Mark R. Somerfield
Mark R. Somerfield American Society of Clinical Oncology

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine opens doors to a variety of healthcare roles. Many students consider alternative or complementary online programs that offer flexibility and specialized knowledge. For example, those interested in preventative health may pursue an online BS in nutrition to gain expertise in dietetics and wellness.

The expanding field of health administration attracts students seeking leadership positions in hospitals or clinics. Accredited graduate programs, like online MHA programs CAHME accredited, are designed for future healthcare managers and can often be completed remotely.

Registered nurses aiming to advance their careers may ask, does RN to BSN require clinicals? Many online RN to BSN programs offer coursework that can be completed with few or no in-person clinical requirements, allowing for career growth without relocation.

For those pursuing the highest level of clinical nursing education, fastest online DNP programs provide an accelerated track to a Doctor of Nursing Practice, enabling nurses to move quickly into advanced practice, administration, or academia.

Best Scientists Citing Gary H. Lyman

Trending Scientists

Recently Published Articles